Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer

Clinical trial NCT06130826 · RECRUITING

Trial details

NCT number: NCT06130826
Sponsor: City of Hope Medical Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Carcinoma Colorectal Carcinoma

Start date: 2025-05-27
Primary completion: 2026-09-05
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.